Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-01-04 @ 2:20 PM
Study NCT ID:
NCT00274495
Status:
TERMINATED
Last Update Posted:
2007-11-01
First Post:
2006-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver
Sponsor:
Beth Israel Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-09
First Submit QC Date:
None
Study First Post Date:
2006-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-10-31
Last Update Post Date:
2007-11-01
Last Update Post Date Type:
ESTIMATED